This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License
Zymergen is an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms. Shortly after going public in 2021, it was reported that the company was facing difficulties in manufacturing products and struggling to make revenue. In July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:foundingYear |
|
| dbo:industry | |
| dbo:keyPerson | |
| dbo:locationCity | |
| dbo:parentCompany | |
| dbo:type | |
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID |
|
| dbo:wikiPageLength |
|
| dbo:wikiPageRevisionID |
|
| dbo:wikiPageWikiLink |
|
| dbp:hqLocationCity | |
| dbp:hqLocationCountry |
|
| dbp:industry | |
| dbp:keyPeople |
|
| dbp:name |
|
| dbp:parent | |
| dbp:tradedAs |
|
| dbp:type | |
| dbp:wikiPageUsesTemplate | |
| dct:subject | |
| rdf:type | |
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| prov:wasDerivedFrom | |
| foaf:homepage | |
| foaf:isPrimaryTopicOf | |
| foaf:name |
|
| is dbo:wikiPageWikiLink of | |
| is foaf:primaryTopic of |